期刊文献+

瑞舒伐他汀与氟伐他汀治疗不稳定型心绞痛的对比研究 被引量:2

Contrast Research Between Rosuvastatin and Fluvastatin with Treatment Unstable Type of Angina
下载PDF
导出
摘要 目的对比瑞舒伐他汀与氟伐他汀治疗不稳定型心绞痛的疗效。方法选取在我院内科住院的不稳定型心绞痛患者86例,随机分为两组,瑞舒伐他汀组在常规治疗(硝酸酯类、钙离子拮抗剂、抗血小板药物、抗凝血药物)基础上给予瑞舒伐他汀10 mg,氟伐他汀组在常规治疗基础上给予氟伐他汀40 mg,每晚1次,共用药8周,测定治疗前后病人LDL-C、HDL-C和CRP水平及患者心绞痛改善情况。结果瑞舒伐他汀组和氟伐他汀组治疗前各指标比较差异均无显著性(P>0.05)。瑞舒伐他汀组和氟伐他汀组治疗后各项指标及疗效相比差异均有显著性(P<0.05)。结论瑞舒伐他汀和氟伐他汀都能够改善不稳定型心绞痛患者的心绞痛症状,但是瑞舒伐他汀治疗不稳定型心绞痛患者的效果明显优于氟伐他汀。 Objective To contrast rosuvastatin and fluvastatin with treatment unstable type of angina.Methods The 86 patients with unstable type of angina in this medical hospital were randomly divided into two groups.Rosuvastatin group was given rosuvastatin 10mg in basis treatment(including nitrates,calcium antagonists,antiplatelet drugs and anticoagulant drugs);Fluvastatin group was given fluvastatin 40mg in basis treatment.All patients taked drug once every night for 8 weeks.Test LDL-C,HDL-C and CRP level and observe the changes of the before and after treatment.Results Before treatment,two groups were compared no significant difference(P0.05).After treatment,the various indicators and curative effect had significant difference between two groups(P0.05).Conclusion Both rosuvastatin and fluvastatin can improve the symptoms of angina,but the clinical effect of rosuvastatin is better than that of fluvastatin.
作者 郝振
出处 《哈尔滨医药》 2011年第2期86-87,共2页 Harbin Medical Journal
关键词 瑞舒伐他汀 氟伐他汀 不稳定型心绞痛 对比 Rosuvastatin Fluvastatin Unstable type of angina Contrast
  • 相关文献

参考文献6

  • 1Libby P.Current concepts of the pathogenesis of the acute coronary syndromes[J].Circulation,2001,104:365-372.
  • 2全国高胆固醇血症控制状况多中心研究协作组.高胆固醇血症临床控制状况多中心协作研究——达标率及影响因素[J].中华心血管病杂志,2002,30(2):109-114. 被引量:176
  • 3Michacld,Patricke,Evanns,et al.Comparison of effects on lowdensitylipoprotein and cholesterol with rosuvastatinversusatorvastatin in patients with type 11 a or 11 bhypercholesterolemia[J].J Am Cardiol,2002,89 (2):268-275.
  • 4Quirk J,Thornton M,Kirkpatrick P.Rosuvastatin calcium[J].Nat Rev Drug DiSCOV,2003,2(10):769-776.
  • 5Anton FH,Stalenhoe F,Christie M,et al.A Comparative study with rosuvastatinin subjects with MET abolicSyndrome:resullts of the COMESTS study.European Heart Journal,2005,24:2664.
  • 6Fonseca FA H,Ruiz A,Silva JM,et al.The discovery penta study a direct statin comparison of LDL-C value = an evaluation og rosuvastatin therapy compared with atovastatin[J].Curt Med Res Opin,2005,21:1307-1315.

二级参考文献10

  • 1Slamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol a nd risk of premature death from coronary heart disease continuous and graded ? F indings in 356,222 primary screenees of the Multiple Risk Factor Intervention Tr ial (MRFIT). JAMA, 1986,256:2823-2828.
  • 2Castelli WP, Garrison RJ,Wilson PwF, et al. Incidence of coronary heart disea se and lipoprotein cholesterol levels: the Framing ham Study. JAMA, 1986, 256:28 35-2838.
  • 3Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S).Lancet,1994,344:1383 -1389.
  • 4Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary- prevention t ri al with gemfibrozil in middle-aged men with dislipidemia. Safety of treatment ,c hages in risk factors, and incidence of coronary heart disease. N Engl J Med, 1 987,317:1237-1245.
  • 5Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease wit h pravastatin in men with hypercholesterolemia. West of Scotland Coronary Preven tion Study Group. N Engl J Med,1995,333:1301-1307.
  • 6Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary e v ents with lovastatin in men and women with average cholesterol levels: results o f AFCAPS/TexCAPS. Air Force/Texas Coronary Artherosclerosis Prevention Study. JAMA .1998;279:1615-1622.
  • 7Summary of the second report of the National Cholesterol Education Program (NC EP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholestero l in Adults ( Adult Treatment Panel II Report). JAMA, 1993, 269:3015-3023.
  • 8Report of the National Cholesterol Education Program Expert Panel on Detection , Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Pan el. Arch Intern Med, 1998, 148:36-69.
  • 90 Pearson TA, Laurora I, Chu H, et al. The lipid treatment assessment project (L -TAP):a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein choles terol goals. Arch Intern Med, 2000, 160:459-467.
  • 10方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献175

同被引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部